Burrell Terry-Ann 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Jul 14, 2023
Insider Transaction Report
Form 4
Burrell Terry-Ann
Director
Transactions
- Sale
Class A Common Stock
2023-07-12$11.25/sh−24,302$273,400→ 147,545 total - Sale
Class A Common Stock
2023-07-12$14.08/sh−3,157$44,457→ 63,122 total - Sale
Class A Common Stock
2023-07-12$12.15/sh−78,071$948,289→ 69,474 total - Sale
Class A Common Stock
2023-07-12$13.18/sh−3,195$42,124→ 66,279 total - Sale
Class A Common Stock
2023-07-13$12.59/sh−8,275$104,143→ 54,847 total
Footnotes (6)
- [F1]Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022.
- [F2]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.60 to $11.59 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F3]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.60 to $12.54 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F4]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.76 to $13.72 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F5]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.81 to $14.56 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F6]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.105 to $12.98 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.